Contract Manufacturing News: Breaking Contract Manufacturing News, Comments and Articles. - Page: 3

Mesothelioma Victims Center Urges Victims Of Mesothelioma Who Worked In Manufacturing To Call Them For Instant Access To The Most Skilled Lawyers-Get Much Better Results

The Mesothelioma Victims Center is urging diagnosed victims of mesothelioma, or their family members to call them for instant access to the nation's most experienced, and skilled mesothelioma lawyers, because mesothelioma compensation claims frequently exceed a million dollars for manufacturing, or industrial workers, and the law firms, or specific lawyers the group recommends to the victim, o...

Dialysis Equipment Manufacturing in the US Industry Market Research Report Now Available from IBISWorld

An aging population will ensure demand for dialysis treatment over the next five years, and a recovered economy will encourage the replacement of new dialysis equipment. For these reasons, industry research firm IBISWorld has added a report on the Dialysis Equipment Manufacturing industry to its growing industry report collection. Los Angeles, CA (PRWEB) May 16, 2013 Despite growing demand for di...

Liquid Health, Inc. Announces the Winner of their Prenatal Vitamin Giveaway

To promote their new prenatal vitamin, Liquid Health, Inc. recently held a contest to give away a 9-month supply of the product. The winner, Carie A. of Port Orchard, WA, was randomly chosen on Friday, May 10, 2013. Murrieta, CA (PRWEB) May 16, 2013 In an effort to generate excitement about their new product, Liquid Health, Inc. held a giveaway in conjunction with the release of the Liquid Prena...

Nordion, Navidea sign contract manufacturing agreement

Nordion has entered into a contract manufacturing agreement with Navidea Biopharmaceuticals for NAV5001 a diagnostic imaging agent used to detect Parkinsonian Syndromes and Dementia with Lewy Bodies.

Amgen-Zhejiang Beta China JV to Include R&D, Manufacturing

Last week, Amgen and Zhejiang Beta Pharma announced they would form a JV to bring Amgen’s biologic drugs to China, starting with Amgen’s colon cancer drug Vectibix. Now, an Amgen spokesperson told China Daily the JV will include a China-b...

Helsinn Group and Eisai Inc. Announce Top-Line Results for Pivotal Studies of the Investigational Fixed-Dose Combination of Netupitant and Palonosetron for Prevention of Chemotherapy-Induced Nausea and Vomiting

LUGANO, Switzerland and WOODCLIFF LAKE, N.J., May 16, 2013 /PRNewswire/ -- Helsinn Group and Eisai Inc. announced today top-line results from Helsinn's pivotal clinical studies investigating the oral fixed-dose combination of netupitant and palonosetron (NEPA) being evaluated for the proposed indication of prevention of chemotherapy-induced nausea and vomiting (CINV).  These data will be...

Alkaline Ionized Water Treatment for Cancer is Examined in Today’s Bawell Water Ionizer Health News Report

Today, the Bawell Water Ionizer Health News published information from the Independent Cancer Research Foundation about the positive effects of alkaline ionized drinking water when used for treating cancer. Boca Raton, FL (PRWEB) May 15, 2013 Drinking alkaline ionized water to treat cancer is covered in the Bawell Water Ionizer Health News report that was published earlier today. The health news...

California Physician Groups Congratulate Marilyn Tavenner on Her Confirmation

California Association of Physician Groups: Statement from Donald CranePresident and CEOCalifornia Association of Physician Groups “The California Association of Physician Groups (CAPG) congratulates Marilyn Tavenner on her Senate Confirmation as CMS Administrator. CAPG and its members look forward to continuing to work with Ms. Tavenne...

Response Genetics, Inc. Announces Contract With Blue Shield of California

LOS ANGELES, May 16, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has entered into an agreement with health insurer Blue Shield of California to join all of Blue Shield of California's provider networks. The agreement...

DRC Reports Extension of Veterans Relationship Management Contract

ANDOVER, Mass., May 16, 2013 (GLOBE NEWSWIRE) -- Dynamics Research Corporation (Nasdaq:DRCO), a leading technology and management consulting company focused on driving performance, process and results for government clients, today reported that the Department of Veterans Affairs (VA), through the General Services Administration, has exercised the third option year of the Veterans Relationship Man...

Chembio Enters Into Six-Month Follow-On Contract With CDC Contractor for Development of Rapid, Point-of-Care Influenza Immunity Test

MEDFORD, N.Y., May 16, 2013 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care (POC) diagnostic tests for infectious diseases, announces that the Company has entered into a follow-on, milestone-based development agreement with a private contracting organization that is engaged to enter into, implement and provide technical oversight of agreements relating to pa...

Conference Tackles Role of Biotherapeutic Drugs and Biosimilars, Harmonization of Regulatory Standards

Conference focuses on challenges in manufacturing biotherapeutics, evaluation and registration of biotherapeutic and biosimilar products, immunogenicity and safety monitoring, interchangeability, and pharmacovigilance.

Nordion, Navidea Sign Manufacturing Contract

Will cover manufacture and supply of diagnostic imaging agent for trials

Sexy and Bold “Dogma” Thigh-High Sandals from Haus Von Lila® are Headed for the US Designer Footwear Market

Following its smash hit debut at the recent Magic Shoe Exhibition in Las Vegas, the show-stopping thigh-high “Dogma” sandal design by Haus Von Lila™ has completed its first production run and is now headed for the US shoe market. Winnie Peng of http://www.Shoe-Manufacturer.com advises savvy designer-shoe collectors to reserve their pair of Dogma from Haus Von Lila® as this first shipmen...

WIL Research Partners with Three S Japan to Expand Full Portfolio of Global Safety Assessment Services to the Japanese Market

WIL Research, a leading global CRO in the pharmaceutical, chemical and agrochemical industries, is partnering with Three S Japan, a company that provides support services in these industries, to represent its full portfolio of global safety assessment services in Japan. WIL Research offers a blend of technical and regulatory expertise in...

PHH selects CareTech's iDoc Archive solution for secure data storage

Port Huron Hospital (PHH) has signed a three year contract to use the CareTech's iDoc Archive solution for secure storage of patient data as the hospital transitions from its old clinical system to the new one.

Kindred Healthcare to Present at the UBS Global Healthcare Services Conference

Company’s Investor Day to be Held on May 21 Kindred Healthcare, Inc. (“Kindred” or the “Company”) (NYSE:KND) today announced that Paul J. Diaz, Chief Executive Officer, and Benjamin A. Breier, President and Chief Operating Officer, will make a presentation regarding the Company at the UBS Global Healthcare Services Conference in New York City...

Nordion Signs Contract Manufacturing Agreement with Navidea Biopharmaceuticals

Nordion Inc. (TSX: NDN) (NYSE: NDZ), a leading provider of products and services to the global health science market, today announced it has signed a contract manufacturing agreement with Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals. Under terms of the agreement, Nordion will manufact...

Navidea Biopharmaceuticals Signs Manufacturing and Supply Agreement with Nordion

– Nordion to Produce and Distribute Supplies of 123I-labeled Drug Product NAV5001 for Late-Phase Clinical Trials – Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced that it has entered into an agreement with Nordion (Canada) Inc. to produce and supply...

Pain Medication OTC Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld

More players are expected to enter the Pain Medication OTC Manufacturing industry over the next five years as patents expire. For this reason, industry research firm IBISWorld has added a report on the Pain Medication OTC Manufacturing in Australia to its growing industry report collection. Melbourne, Australia (PRWEB) May 16, 2013 The Pain Medication OTC Manufacturing industry manufactures pharm...

Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the 2013 UBS Global Healthcare Conference on Wednesday, May 22, 2013 at 8:00 a.m. ET at The Sheraton New York Hotel in New York City. A live audio webcast of the presentation will be available on the...

Aoxing Pharmaceutical Company, Inc. Announces Financial Results For Third Quarter Of 2013 Fiscal Year

JERSEY CITY, N.J., May 15, 2013 /PRNewswire/ -- Aoxing Pharmaceutical Company, Inc. (NYSE MKT: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals, today announced its financial and operational results for the three and nine month periods ended March...

Vasomedical Announces Financial Results for the First Quarter of 2013

WESTBURY, N.Y., May 15, 2013 /PRNewswire/ -- Vasomedical, Inc. ("Vasomedical") (OTC BB: VASO) today reported its operating results for the three months ended March 31, 2013. "We are pleased to report that for the first quarter of 2013, we recorded total revenue of $7.3 million, an increase of 21% compared to the same period of 2012," commented Dr. Jun Ma, President and Chief Executive Officer of...

A.M. Best Affirms Ratings of Centene Corporation and Its Subsidiaries

A.M. Best Co. has affirmed the issuer credit rating (ICR) of “bb” and debt rating of “bb” on $425 million 5.75% senior unsecured notes, due 2017 of Centene Corporation (Centene) (Delaware) [NYSE: CNC]. Concurrently, A.M. Best has affirmed the financial strength rating (FSR) of B++ (Good) and ICRs of “bbb” of Absolute Total Care, Inc. (Columbia,...

Sanofi Reprimanded by French Authorities For Slanderous Sales Tactics

Précis:  Forceful efforts to thwart generic drug competition in France have landed multinational pharma firm Sanofi in deep water with the country’s Competition Authority, which has just issued a �...